Evidence map›Paper›PMID 21765899›Full record

ArticlePloS one2011

Out-of-frame T cell receptor beta transcripts are eliminated by multiple pathways in vivo.

Grace K Mahowald, Michael A Mahowald, Clara Moon, Bernard Khor, Barry P Sleckman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Grace K MahowaldDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, Missouri, United States of America.
Michael A Mahowald
Clara Moon
Bernard Khor
Barry P Sleckman
Washington University in St. Louis · US

Funding

Viral Discovery in Rheumatoid ArthritisP30AR048335 · NIAMS · WASHINGTON UNIVERSITY · PI ATKINSON, JOHN · 2001 to 2015
$8.9M
THE V(D)J RECOMBINATION REACTION AND ITS IMPACT ON LYMPHOCYTE DEVELOPMENTR01AI047829 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI SLECKMAN, BARRY P · 2000 to 2021
$7.0M
ANIMAL SPACE FOR CARDIOVASCULAR AND ONCOLOGY RESEARCHC06RR012466 · NCRR · WASHINGTON UNIVERSITY · PI CICERO, THEODORE J · 1997 to 1997
–
NCRR NIH HHS RR012466NIAID NIH HHS AI47829NIAID NIH HHS R01 AI047829NIAMS NIH HHS P30 AR048335NIAMS NIH HHS P30-AR48335
6 · The paper itself

Abstract

Non-productive antigen receptor genes with frame shifts generated during the assembly of these genes are found in many mature lymphocytes. Transcripts from these genes have premature termination codons (PTCs) and could encode truncated proteins if they are not either inactivated or destroyed by nonsense-mediated decay (NMD). In mammalian cells, NMD can be activated by pathways that rely on the presence of an intron downstream of the PTC; however, NMD can also be activated by pathways that do not rely on these downstream introns, and pathways independent of NMD can inactivate PTC-containing transcripts. Here, through the generation and analysis of mice with gene-targeted modifications of the endogenous T cell receptor beta (Tcrb) locus, we demonstrate that in T cells in vivo, optimal clearance of PTC-containing Tcrb transcripts depends on the presence of an intron downstream of the PTC.

Indexed as

AllelesAnimalsCodon, NonsenseMiceReading FramesReceptors, Antigen, T-Cell, alpha-betaRNA, MessengerRNA StabilityT-LymphocytesCodon, NonsenseReceptors, Antigen, T-Cell, alpha-betaRNA, Messenger

Identifiers

PMID21765899
PMCPMC3135592
OpenAlexW2025039496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.